Evidence map›Paper›PMID 41774387›Full record

ArticleDiscover mental health2026

Prevalence, outcomes, and effective interventions for anxiety disorders in children and adolescents.

Mohsen Khosravi

Abstract read
In one paragraph

Article in Discover mental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Mohsen KhosraviDepartment of Psychiatry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, 9813913777, Iran. dr_khosravi2016@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnxiety disorders are common in children and adolescents worldwide and can seriously affect their functioning and well-being. They often continue into adulthood and are linked to other psychiatric problems. Although treatments have improved, significant challenges remain, especially in non-Western regions due to cultural and access barriers.

objectiveThis systematic narrative review aimed to synthesize international and Persian literature (2005-2024) regarding the prevalence, outcomes, and effectiveness of interventions for anxiety disorders in children and adolescents, with specific attention to the Iranian context.

methodsFollowing the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, comprehensive searches were conducted across international (PubMed, PsycINFO, Scopus, Cochrane) and Persian (SID, MagIran) databases. Sixty-four studies were included based on predefined eligibility criteria. Data extraction and quality assessment were performed independently by two reviewers, and a narrative synthesis approach was employed due to heterogeneity across studies.

resultsFindings confirm high prevalence and chronicity of anxiety disorders in youth globally and in Iran. Untreated anxiety is consistently linked to academic impairment, social withdrawal, and increased risk for future psychopathology. Cognitive-behavioral therapy (CBT) emerged as the most effective intervention, with response rates of 55-65%, especially when combined with selective serotonin reuptake inhibitors (SSRIs), which further increased success rates to approximately 75-80%. Family-based and school-based interventions also demonstrated efficacy, though cultural adaptation remains limited. Systemic barriers, including provider shortages and stigma, impede care in resource-limited settings such as Iran.

conclusionAnxiety disorders in youth constitute a major public health concern requiring culturally sensitive, evidence-based interventions. While CBT and combined treatments are effective, future research should focus on cultural adaptation, innovative delivery models, and system-level solutions to bridge the treatment gap in low- and middle-income countries.

Indexed as

AdolescentAnxiety disordersChildOutcomePrevalenceTherapeuticsTreatment

Identifiers

PMID41774387
PMCPMC13062052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.